We are live on ! Find out more
TECH icon

Bio-Techne

327 hedge funds and large institutions have $5.12B invested in Bio-Techne in 2018 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 118 increasing their positions, 112 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

244% more call options, than puts

Call options by funds: $1.04M | Put options by funds: $303K

5% more repeat investments, than reductions

Existing positions increased: 118 | Existing positions reduced: 112

3.63% less ownership

Funds ownership: 380.19%376.56% (-3.6%)

5% less funds holding

Funds holding: 343327 (-16)

28% less first-time investments, than exits

New positions opened: 38 | Existing positions closed: 53

30% less capital invested

Capital invested by funds: $7.32B → $5.12B (-$2.19B)

67% less funds holding in top 10

Funds holding in top 10: 62 (-4)

Holders
327
Holders Change
-16
Holders Change %
-4.66%
% of All Funds
7.29%
Holding in Top 10
2
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-66.67%
% of All Funds
0.04%
New
38
Increased
118
Reduced
112
Closed
53
Calls
$1.04M
Puts
$303K
Net Calls
+$739K
Net Calls Change
+$1.27M
Name Holding Trade Value Shares
Change
Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$47.5M -$4.03M -96,468 -7%
1WCM
27
12 West Capital Management
New York
$46.5M +$5.01M +120,000 +10%
CCA
28
Conestoga Capital Advisors
Pennsylvania
$46.2M +$1.67M +39,980 +3%
RA
29
Royce & Associates
New York
$43.2M -$6.6M -158,052 -12%
O
30
OppenheimerFunds
New York
$39.3M -$16.2M -387,948 -26%
SBH
31
Segall Bryant & Hamill
Illinois
$38.4M -$1.72M -41,128 -4%
KCM
32
Kornitzer Capital Management
Kansas
$37.1M -$3.64M -87,264 -8%
SEI Investments
33
SEI Investments
Pennsylvania
$36.4M +$607K +14,524 +2%
Dimensional Fund Advisors
34
Dimensional Fund Advisors
Texas
$30.2M -$536K -12,840 -2%
Charles Schwab
35
Charles Schwab
California
$29.7M +$148K +3,540 +0.4%
Goldman Sachs
36
Goldman Sachs
New York
$28.6M -$679K -16,252 -2%
Select Equity Group
37
Select Equity Group
New York
$26.1M +$30.1M +720,492 New
Macquarie Group
38
Macquarie Group
Australia
$25.5M -$633K -15,164 -2%
Principal Financial Group
39
Principal Financial Group
Iowa
$24.2M +$9.86K +236 +0%
Deutsche Bank
40
Deutsche Bank
Germany
$23M +$16.6M +397,060 +166%
SCP
41
Sandhill Capital Partners
New York
$23M +$189K +4,516 +0.7%
American Century Companies
42
American Century Companies
Missouri
$22.7M +$20.1M +482,228 +331%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$18.6M +$4.51M +108,056 +27%
Public Employees Retirement Association of Colorado
44
Public Employees Retirement Association of Colorado
Colorado
$18.5M -$2.67K -64 -0%
PPA
45
Parametric Portfolio Associates
Washington
$16.3M +$58.6K +1,404 +0.3%
BTW
46
Boston Trust Walden
Massachusetts
$15.7M -$6.7M -160,388 -27%
TCIM
47
TIAA CREF Investment Management
New York
$15.3M -$1.51M -36,032 -8%
Bank of America
48
Bank of America
North Carolina
$15.2M -$15.3M -365,964 -47%
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$15M +$288K +6,904 +2%
ACM
50
American Capital Management
New York
$14.6M +$13.3M +317,248 +365%

TECH Hedge Fund Activity: Q4 2018 in Review

327 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q4 2018, worth a combined $5.12B — down 30% from $7.32B a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of TECH and 38 opened new positions — a net loss of 15 holders — while 112 trimmed existing stakes and 118 added.

The largest buyer was Wellington Management Group, adding an estimated $56.5M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $68.6M sold.

  • 327 institutional investors held Bio-Techne (TECH) as of Q4 2018, down from 343 in Q3 2018.
  • Funds reported $5.12B of Bio-Techne stock for Q4 2018, down 30% quarter-over-quarter.
  • 38 funds opened new Bio-Techne positions in Q4 2018 and 53 closed out, a net change of -15 holders.
  • The largest Bio-Techne buyer in Q4 2018 was Wellington Management Group, an estimated $56.5M added.
  • The largest Bio-Techne seller in Q4 2018 was Lord, Abbett & Co, an estimated $68.6M sold.

Based on aggregated 13F filings for Q4 2018.